Managing Persistent and Recurrent Symptoms in Primary Care in Viet Nam: Planned Diagnostic Reassessment, Safety-Netting and Referral Follow-Up

Managing Persistent and Recurrent Symptoms in Primary Care in Viet Nam: Planned Diagnostic Reassessment, Safety-Netting and Referral Follow-Up

A patient returns to a primary care clinic because a symptom has not improved. The initial examination was reassuring, preliminary investigations revealed no clear abnormality, and treatment was prescribed for a plausible explanation. Several weeks later, the symptom persists. At the next visit, the patient may see a different clinician who has limited information about the earlier assessment. Treatment may be adjusted, additional tests ordered, or reassurance offered again without a clear plan for reconsidering the unresolved problem.

This situation does not necessarily indicate that the original diagnosis was incorrect. Many symptoms encountered in primary care are nonspecific, fluctuate over time, or resolve without a definitive explanation. Some conditions become recognizable only after additional clinical features emerge. An assessment that was reasonable at the first consultation may therefore need to change as new information becomes available.

The patient safety concern arises when successive consultations are treated as separate encounters rather than parts of an evolving diagnostic process. Previous findings may not be reviewed, a provisional diagnosis may gradually be accepted as definitive, and responsibility for reassessment may remain unclear. A normal initial test result can provide reassurance even when it does not adequately explain why the patient's symptoms continue.

This is a distinctive challenge for primary care, where diagnostic understanding often develops over time. An unresolved health concern may require several consultations, observations of symptom progression, investigations, and referrals before an appropriate conclusion can be reached.

The World Health Organization's Primary Care Checklist, published in June 2025, emphasizes continuity, coordination, comprehensiveness, and person-centered care. Its ten components include reviewing healthcare contacts since the previous visit, updating diagnoses and problem lists, and discussing and documenting follow-up arrangements, including circumstances requiring urgent assessment.

Research published in 2026 has also highlighted the importance of making unresolved diagnostic questions visible. Studies examining primary care records and electronic symptom-tracking systems have identified opportunities to improve how earlier assessments are reconsidered and how follow-up responsibilities are maintained across multiple encounters.

For healthcare organizations in Viet Nam, the challenge is to establish practical arrangements that help clinicians recognize when an earlier diagnostic assessment needs another look, clarify what should happen next, and ensure that clinically important investigations or referrals are not lost between visits.

The objective is not to investigate every persistent symptom extensively or assume that repeated consultations represent diagnostic failure. It is to make the diagnostic process responsive to changes in the patient's condition while ensuring that appropriate reassessment and follow-up do not depend entirely on individual memory.

Why Persistent and Recurrent Symptoms Require Reassessment Over Time

Symptoms do not always follow a predictable course. Some remain present, others disappear and return, and some gradually change in severity or develop additional features.

A persistent symptom continues beyond the period in which improvement was expected or remains insufficiently explained. A recurrent symptom improves or resolves before returning. A progressive symptom becomes more severe or develops characteristics that may alter its clinical significance.

These descriptions are useful for understanding symptom patterns, but they are not rigid diagnostic categories. Their meaning depends on the presentation, duration, associated findings, relevant risk factors, and the patient's overall clinical circumstances.

Many persistent or recurrent symptoms are associated with conditions that are not serious. Further investigations may be unnecessary when the available evidence supports an appropriate clinical assessment and management plan. Nevertheless, some symptoms may represent early manifestations of conditions that were difficult to recognize during the initial consultation.

Unintentional weight loss, unexplained anemia, persistent abdominal symptoms, or recurrent urinary abnormalities illustrate situations in which the clinical significance may become clearer as additional information emerges. None automatically establishes cancer or another serious disease. However, an inconclusive initial assessment should not be mistaken for a definitive explanation when meaningful clinical uncertainty remains.

An unresolved diagnostic question exists when the available information does not yet provide a sufficiently supported explanation for the patient's condition. This may be an appropriate conclusion following an initial consultation, particularly when the clinician has considered the available evidence and established a suitable management plan.

A potential missed diagnostic opportunity is different. It arises when information suggests that an appropriate assessment, investigation, reassessment, or communication may not have occurred. Determining whether an actual diagnostic error took place requires further professional evaluation of the relevant evidence and the opportunities reasonably available at the time.

These distinctions matter because persistent symptoms alone do not establish that an earlier diagnosis was incorrect. Similarly, identifying serious disease after several consultations does not necessarily mean that previous care was inappropriate.

For quality improvement, the more useful question is whether the diagnostic process remained responsive to the information available as the patient's condition evolved.

What Recent Evidence Reveals About Diagnostic Follow-Up

A study published online in BMJ Quality & Safety in September 2026 examined diagnostic safety concerns identified through structured medical record review in Swedish primary care.

Fernholm and colleagues reviewed 1,116 patient records from 27 primary care centers in Region Stockholm. The records concerned patients aged 40–75 years with selected nonspecific symptoms or findings that may sometimes be associated with serious conditions, including cancer.

The reviewers identified at least one diagnostic safety concern in 358 records, representing approximately 32% of the selected sample.

The most frequently identified concern was the absence of documented differential diagnostic reasoning, found in 21% of records. Insufficient clinical information was identified in 18%, while the reviewers identified failure to consider alternative diagnoses in 12% based on the documented assessments.

The qualitative analysis highlighted recurring vulnerabilities involving diagnostic reasoning that was not visible in the record, narrow diagnostic framing, insufficient reconsideration of earlier assessments, and fragmented care across multiple encounters.

These findings are relevant to diagnostic continuity, but their interpretation requires caution.

The study examined selected records from one Swedish healthcare region. Its findings represented concerns identified through retrospective review, not a confirmed diagnostic error rate. An absence of documented reasoning also does not establish that the clinician failed to consider the relevant possibilities during the consultation.

The results therefore cannot be interpreted as the prevalence of diagnostic errors in primary care generally or directly applied to healthcare services in Viet Nam.

Their practical significance lies in showing how an unresolved diagnostic question can become difficult to manage when earlier reasoning, outstanding concerns, and intended next steps are not clearly recorded.

A second study, published in the October 2026 issue of The Joint Commission Journal on Quality and Patient Safety, examined a different approach.

Salant and colleagues designed and tested an electronic health record-based system for tracking concerning symptoms in a community primary care clinic in Boston.

The system allowed clinicians to identify symptoms requiring continued attention and monitor whether follow-up occurred. Compared with historical records, documented symptom follow-up increased from 60.5% to 84.8%, while the reported mean interval to follow-up decreased from 101.6 to 20 days.

These results support the feasibility of structured symptom tracking. However, the study was a single-site pilot using a historical comparison rather than a randomized evaluation. Improved documentation and timeliness did not, by themselves, establish that the intervention reduced confirmed diagnostic errors or patient harm.

Together, the studies suggest an important direction for quality improvement: clinically significant unresolved diagnostic questions should remain visible, and appropriately selected patients should have dependable opportunities for reassessment when their symptoms or circumstances justify further attention.

Planned Diagnostic Reassessment: Asking Whether the Earlier Explanation Still Fits

A repeat consultation does not automatically constitute meaningful diagnostic reassessment.

A patient may return several times without the original working diagnosis being reconsidered. Each visit may address the immediate complaint while giving limited attention to the cumulative pattern of symptoms and previous findings.

Planned diagnostic reassessment is an intentional opportunity to review the patient's condition, compare its progression with the expected course, and determine whether the working diagnosis and management plan remain appropriate.

This approach is particularly relevant when symptoms remain unexplained, the diagnosis is provisional, improvement has not occurred as expected, or new information raises concern about an earlier conclusion.

The reassessment should consider what was known at the previous consultation, what has changed, and whether those changes affect the earlier clinical assessment.

Relevant information may include symptom duration and progression, associated findings, treatment response, previous investigations, and healthcare contacts since the last visit. Information about medication use, adherence, adverse effects, or changes in the patient's circumstances may also be relevant.

Treatment response can provide useful information, but improvement or lack of improvement should not automatically be treated as confirmation or exclusion of a particular diagnosis.

Temporary improvement may occur even when an underlying condition remains unresolved. Conversely, failure to improve may reflect an incorrect initial hypothesis, disease progression, treatment-related factors, or another circumstance requiring evaluation.

The central question is whether the earlier explanation remains consistent with the available evidence.

When reassessment is clinically justified, the plan should identify its purpose, an appropriate timeframe, and the clinician or service responsible for the next assessment.

The interval should reflect clinical risk and the expected course of the condition. Not every symptom requires a scheduled return appointment. For selected low-risk presentations, patient-initiated reassessment may be reasonable when the person understands the circumstances that should prompt another consultation.

Other situations may warrant proactive follow-up because the consequences of missed reassessment are potentially greater or because the patient faces barriers to returning for care.

A predetermined number of visits should not automatically trigger investigations or specialist referral. Equally, the absence of a numerical threshold should not allow clinically important unresolved symptoms to be dismissed indefinitely.

Planned reassessment allows changes over time to contribute to diagnostic understanding without making repeated testing the default response.

When Normal Test Results Do Not Resolve the Clinical Question

Laboratory investigations and diagnostic imaging can provide valuable reassurance, but their meaning depends on the clinical question they were intended to address.

A normal result may reduce the likelihood of certain conditions without excluding every possible explanation for the patient's symptoms.

Its significance depends on the examination's characteristics, the timing of testing, the condition being investigated, and the patient's clinical circumstances.

A test may also be technically accurate without resolving the broader diagnostic question.

For example, an initial laboratory assessment may fail to identify a clear cause of persistent fatigue or unexplained weight loss. The absence of a particular abnormality does not necessarily establish that the patient's condition has been adequately explained.

Similarly, an imaging examination may answer a specific clinical question without evaluating every relevant diagnostic possibility.

When symptoms persist or change, the clinician may need to reconsider what the earlier investigation established, which possibilities it meaningfully reduced, and whether subsequent findings justify another approach.

This should not result in repeated testing simply because previous results were normal.

Unnecessary investigations can increase costs, create anxiety, generate incidental findings, and lead to interventions that may not improve patient outcomes.

The decision to investigate further should follow an appropriate reassessment of the clinical situation.

In some circumstances, observation and a clear follow-up plan may be preferable to immediate additional testing. In others, new findings or continuing symptoms may justify a different investigation or specialist consultation.

The essential safeguard is to avoid treating a negative result as the automatic endpoint of diagnosis when a clinically significant question remains unresolved.

Documentation should help subsequent clinicians understand why an investigation was requested, what the result established, and whether further assessment remains necessary.

Safety-Netting: Planning for What Happens Next

Safety-netting is an important approach to managing diagnostic uncertainty when immediate further investigation or referral is not considered necessary.

In primary care, safety-netting involves establishing an appropriate plan for what should happen if symptoms persist, recur, worsen, or change in a way that requires reassessment.

This may involve a scheduled review, instructions for patient-initiated reassessment, information about changes requiring urgent attention, and a clear route for obtaining further clinical advice.

Safety-netting is more than a general instruction to return if the patient feels worse.

A meaningful plan should reflect the patient's presentation, the uncertainty that remains, and the expected course of the condition.

The clinician should explain what the current assessment suggests, what has not yet been established, and why observation or a particular follow-up approach is appropriate.

The patient should understand which changes would justify earlier reassessment and how to obtain appropriate care if those changes occur.

Where relevant, the plan should also clarify when improvement is expected or when another assessment may be needed if symptoms continue.

The National Institute for Health and Care Excellence (NICE) addresses these principles in guideline NG12, Suspected Cancer: Recognition and Referral.

The guideline recommends considering review for people whose symptoms are associated with increased cancer risk but do not meet the criteria for immediate referral or investigation.

The review may be planned within an agreed timeframe or initiated by the patient if new symptoms develop, concern continues, or symptoms persist, recur, or worsen.

NICE also emphasizes that investigation results should be reviewed and acted upon appropriately, with the requesting healthcare professional retaining responsibility or explicitly transferring it to another professional.

These safety-netting recommendations date from 2015. Although NICE NG12 was updated on April 15, 2026, that update concerned selected recommendations relating to gynecologic cancers and non-site-specific weight loss rather than introducing a new general safety-netting framework.

The principles of communicating uncertainty and arranging appropriate reassessment can inform quality improvement beyond suspected cancer care. However, NICE NG12 is a United Kingdom guideline. Its specific referral thresholds, clinical pathways, and service timelines should not automatically be applied as professional or legal requirements in Viet Nam.

Safety-netting must also distinguish routine reassessment from urgent clinical deterioration.

A patient who develops signs suggesting an acute or serious condition may need immediate medical evaluation rather than waiting for a previously scheduled appointment. The appropriate response must be determined by the responsible healthcare professionals according to the clinical circumstances.

Patient understanding is essential, but responsibility should not be transferred entirely to the patient.

Health literacy, language, disability, age, financial constraints, and difficulty accessing healthcare may affect whether an individual understands or can act on the follow-up plan.

A patient-initiated approach may be appropriate in some circumstances but insufficient in others. Where clinically justified, proactive contact or additional coordination may be necessary.

The goal is a dependable contingency plan that combines appropriate professional oversight with the patient's informed participation.

Keeping Unresolved Diagnostic Questions Visible Across Visits

Persistent and recurrent symptoms can become more difficult to evaluate when important information is distributed across different consultations or healthcare facilities.

A patient may attend a local clinic, undergo investigations at another provider, obtain a specialist opinion elsewhere, and subsequently return to the original service.

Each encounter may be clinically appropriate when considered individually. However, the diagnostic process can remain fragmented if the information accumulated through these visits is not brought together.

One clinician may be unaware of a previous investigation. Another may not know that a recommended referral was never completed. A third may treat a recurring symptom as a new complaint because the earlier assessment is difficult to locate.

The problem is not simply the number of consultations. It is whether the information generated during those consultations contributes to subsequent decisions.

A useful clinical record should make the current diagnostic position understandable to the next professional involved.

It should identify the principal unresolved problem, the working assessment, relevant previous findings, important outstanding questions, and the intended follow-up plan.

Where appropriate, the record should explain why further investigation was not considered necessary at that stage and what developments would justify reconsideration.

This does not require lengthy documentation of every theoretical alternative diagnosis. Excessive recording may make clinically important information harder to identify.

The objective is to preserve sufficient information about significant decisions so another clinician can understand the current position and recognize when reassessment is needed.

An updated problem list and a concise summary of unresolved diagnostic concerns can be particularly useful when patients see different professionals because of staff rotations, appointment availability, or movement between healthcare organizations.

A provisional diagnosis is not inherently a failure. It becomes more concerning when its provisional nature is no longer apparent, uncertainty is not communicated, or the record suggests that the diagnostic question has been resolved without sufficient support.

Continuity of diagnostic information is therefore important even when continuity with the same clinician cannot always be maintained.

Referral Follow-Up: Ensuring the Next Assessment Actually Occurs

Specialist referral is an important part of primary care when a patient requires expertise, investigations, or services beyond those available in the initial setting.

However, issuing a referral does not establish that the intended assessment has occurred.

A referral may be delayed, declined, redirected, or not attended. The receiving service may require additional information, or the patient may face practical barriers to obtaining an appointment.

These circumstances can interrupt diagnostic progress even when the original decision to refer was appropriate.

A reliable referral should communicate the clinical question requiring specialist assessment, relevant symptoms and findings, previous investigations, and the reasons supporting the requested urgency.

When the diagnosis remains uncertain, that uncertainty should be communicated accurately rather than replaced by an unsupported definitive label.

Referral follow-up should distinguish between a referral being issued, accepted, scheduled, attended, and clinically addressed.

A patient may attend a specialist consultation without the underlying diagnostic question being resolved. Further investigations may be required, or responsibility for ongoing assessment may return to the original healthcare service.

The referral process should therefore support appropriate communication of the specialist's findings and any necessary next steps.

Responsibility for this process should be defined according to the patient's clinical circumstances and the applicable professional and organizational arrangements.

The referring clinician is not necessarily responsible for personally monitoring every subsequent aspect of care indefinitely. Equally, sending a referral should not automatically be treated as confirmation that responsibility has been successfully transferred.

Where a referral has not been completed, the response should reflect the potential consequences of delay.

Some unresolved problems may require further contact or reassessment, while lower-risk situations may be managed through another documented and clinically justified approach.

Patient refusal, inability to establish contact, referral rejection, and confirmed acceptance by another service should be recorded as distinct outcomes rather than combined into a single measure of referral completion.

The purpose is to maintain diagnostic continuity through the transfer of care, not to create an unlimited administrative responsibility for every clinician involved.

Balancing Reassessment Against Unnecessary Investigations

A system designed to prevent missed diagnoses can create other problems if every persistent symptom automatically triggers additional investigations.

Some symptoms resolve spontaneously. Others remain nonspecific despite appropriate clinical evaluation, and a definitive disease label may not always be achievable or necessary.

Repeated testing may increase costs, create anxiety, or identify incidental abnormalities that lead to further investigations without improving patient outcomes.

The decision to investigate or refer should therefore remain grounded in clinical risk, available evidence, changes in the patient's condition, and the likely benefits and harms of additional action.

For some patients, the appropriate outcome of reassessment may be confirmation that no further investigation is currently justified, accompanied by a clear explanation of what should happen if circumstances change.

For others, new information may support additional testing, specialist assessment, or a different management approach.

A quality improvement system should recognize both outcomes rather than use the number of completed investigations as a proxy for better care.

The more meaningful question is whether the patient received appropriate reassessment and whether the subsequent decision reflected the information available at that time.

This balance is particularly important in primary care, where nonspecific symptoms are common and the probability of serious disease may initially be low.

The aim is to recognize meaningful clinical changes without turning diagnostic uncertainty itself into an automatic indication for extensive investigation.

Making Follow-Up Responsibilities Clear

Planned diagnostic reassessment becomes more reliable when the next action has an identifiable responsible professional or service.

Depending on the healthcare setting, this may be the original clinician, another member of the clinical team, or a designated service responsible for coordinating follow-up.

Responsibilities should reflect the activities involved.

A clinician may be responsible for interpreting investigation results and deciding whether reassessment is necessary. A scheduling service may arrange an appointment, while another clinical team may undertake the subsequent consultation.

Administrative support can help coordinate these tasks, but it should not replace professional judgment about the need for further assessment.

Responsibility may also change when the patient moves between services. When this occurs, the relevant information and expected next step should be communicated appropriately.

A plan that identifies a future review without clarifying what happens if the patient does not return may be insufficient in selected higher-risk situations.

Healthcare organizations should therefore consider how important unresolved cases are identified, whether planned reviews have occurred, and what response is appropriate when expected follow-up is missed.

Not every patient with an unresolved symptom needs active tracking. A risk-based approach should focus additional resources on situations in which missed reassessment could have meaningful clinical consequences.

This helps improve reliability without creating a follow-up system so extensive that it becomes difficult to maintain.

Measuring Diagnostic Reassessment and Referral Reliability

Measurement can help primary care organizations determine whether unresolved diagnostic questions are being managed consistently.

However, longitudinal reassessment is more difficult to evaluate than completion of a single test because the appropriate next step depends on the patient's condition.

Useful indicators may include the proportion of selected higher-risk cases with a documented reassessment plan, the proportion reviewed within the clinically agreed timeframe, and the proportion of important referrals for which a subsequent outcome is recorded.

Organizations may also examine whether investigation results were reviewed and acted upon, whether missed appointments were reassessed according to clinical risk, and whether recurring symptoms were reconsidered when patients returned.

These indicators require clearly defined eligible populations.

A measure calculated only among patients who returned to the original clinic may exclude those who received care elsewhere or never attended another appointment.

Similarly, an indicator based exclusively on scheduled visits may overlook patients whose plan appropriately relied on patient-initiated reassessment.

Measurement should therefore distinguish planned reviews, patient-initiated follow-up, and referrals requiring active monitoring.

Timeliness also requires careful interpretation.

A shorter interval between consultations is not necessarily better when an additional visit offers little benefit. Conversely, a longer interval may be clinically appropriate when the patient's risk and expected course justify observation.

Organizations should avoid applying a universal number of days within which all persistent symptoms must be reassessed.

The relevant question is whether follow-up occurred within a timeframe appropriate to the clinical circumstances and agreed plan.

Retrospective case review can provide further insight. Selected cases involving repeated consultations, unresolved findings, unexpected later diagnoses, or delayed specialist assessment may reveal opportunities to improve documentation, communication, and reassessment.

Such reviews should consider what information was available at each stage and which actions were reasonably appropriate at the time.

A later serious diagnosis does not automatically establish that earlier care was incorrect. The purpose of review is to identify potentially missed opportunities and recurring weaknesses without allowing knowledge of the eventual outcome to distort the assessment of earlier decisions.

Digital Symptom Tracking: Useful Support, Not a Substitute for Clinical Judgment

Electronic health records can help clinicians recognize patterns that are difficult to identify during isolated consultations.

Previous symptoms, investigations, referrals, and treatment responses may become easier to review when relevant information is recorded consistently and remains accessible.

Structured fields, updated problem lists, and selected reminders can support the visibility of unresolved diagnostic concerns.

The 2026 study by Salant and colleagues demonstrates one potential approach through an electronic health record-embedded symptom-tracking system.

The intervention improved the documentation and timeliness of follow-up in the participating clinic. However, the evidence remains preliminary and does not establish that similar systems will necessarily reduce diagnostic errors across different healthcare settings.

Broader implementation requires attention to clinical workflow, patient selection, staff responsibilities, and the sustainability of monitoring.

Digital tools can also create additional work if they generate excessive reminders, rely on incomplete information, or fail to recognize that a patient's symptoms have already been appropriately assessed elsewhere.

An automated alert may indicate that a planned review is overdue. It cannot independently determine whether further investigation is necessary or whether the original clinical concern has been adequately resolved.

These decisions remain the responsibility of appropriately qualified professionals.

Organizations without integrated electronic records may begin with a controlled registry or worklist for selected higher-risk unresolved cases.

The value of the system lies in whether it makes clinically important reassessment more reliable, not in how technologically sophisticated it appears.

Applying Diagnostic Reassessment Within Viet Nam's Healthcare System

Primary care and first-contact outpatient services in Viet Nam operate across different organizational settings.

Depending on local arrangements and professional scope, patients may receive initial assessment and follow-up through commune-level healthcare facilities, family medicine services, outpatient clinics, general clinics, or hospital-based ambulatory services.

Not every outpatient consultation provides longitudinal primary care, and not every patient has one clinician responsible for ongoing assessment.

These differences matter when developing systems for diagnostic reassessment.

A facility serving a relatively stable patient population may be able to establish planned reviews through an identified clinical team.

An organization providing primarily episodic consultations may need stronger documentation and communication arrangements when patients are expected to continue assessment elsewhere.

In either setting, procedures should reflect the services' authorized capabilities, available resources, and actual care arrangements.

The Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, provides the principal legal framework relevant to medical examination, treatment, and professional responsibilities.

Article 60 establishes responsibilities of healthcare facilities, including organizing timely medical examination and treatment and complying with applicable professional requirements.

Clause 10 of Article 60 addresses the introduction or transfer of patients to another appropriate healthcare facility in specified circumstances, including when the patient's condition exceeds the facility's professional capabilities or authorized scope.

These provisions should not be interpreted as establishing an automatic requirement to transfer every patient whose symptoms persist. Decisions about referral and transfer must reflect the applicable legal conditions and the patient's clinical circumstances.

Article 64 addresses professional consultation when a condition exceeds the diagnostic or treatment capabilities of a practitioner or healthcare facility, or when treatment has not produced satisfactory progress or the patient's condition has worsened.

The article recognizes consultation within and between healthcare facilities, including international and remote consultation arrangements, and requires consultation results to be documented in the medical record.

However, routine follow-up or internal reassessment of an unresolved symptom should not automatically be classified as formal professional consultation under Article 64. The applicable procedures depend on the nature and circumstances of the activity.

Article 69 establishes requirements concerning medical records, including their creation, updating, preservation, confidentiality, and conditions governing access and use.

These provisions are relevant when documenting clinical assessments, working diagnoses, unresolved questions, investigation results, and subsequent care.

Clear documentation of diagnostic uncertainty and follow-up arrangements can support continuity. However, international safety-netting frameworks should not be presented as specific mandatory documentation procedures under Vietnamese law unless the relevant obligation is independently established.

Referral and transfer arrangements should also comply with applicable professional, organizational, and health insurance requirements where relevant.

International guidelines, including NICE NG12, can inform local quality improvement. Their referral thresholds and service timelines should not automatically be treated as legally binding or universally appropriate requirements for healthcare facilities in Viet Nam.

Healthcare organizations should distinguish professional recommendations for improving diagnostic safety from legal obligations, licensing conditions, and reimbursement arrangements.

Protecting patient information is another important consideration.

Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and its implementing Decree No. 356/2025/ND-CP took effect on January 1, 2026.

Clinical records, symptom-tracking systems, referral registers, and follow-up communications may contain identifiable health information and other personal data.

Healthcare organizations should assess the applicable requirements concerning lawful processing, confidentiality, authorized access, information security, and disclosure or transfer of information between healthcare providers.

Consent requirements, applicable exceptions, and other legal conditions should be considered according to the purpose and circumstances of the processing activity.

Informal communication through inadequately secured channels should not replace appropriately authorized clinical information-sharing arrangements.

A reliable reassessment process should preserve the information needed for continuity of care while protecting patient confidentiality.

Building a Practical Improvement Program for Primary Care

Healthcare organizations do not need to introduce a comprehensive symptom-tracking system for every patient before beginning to improve diagnostic reassessment.

A practical starting point is to identify a limited group of clinical situations in which missed follow-up could have meaningful consequences.

These may include selected unexplained symptoms or findings, repeated consultations without a sufficiently supported explanation, or cases in which a planned reassessment or clinically important referral has not been completed.

Selection criteria should reflect local case mix, clinical risk, professional judgment, and available resources rather than automatically adopting thresholds developed for another healthcare system.

An organization can begin by reviewing a sample of relevant patient records to understand how unresolved diagnostic questions are currently documented and followed.

This may reveal that reassessment is taking place but is poorly recorded. It may also reveal uncertainty about who is responsible, difficulty accessing previous investigations, or failure to recognize when a referral has not been completed.

The response should be tailored to the problem identified.

Where documentation is inadequate, clearer clinical summaries and follow-up plans may improve continuity. Where missed appointments are the main concern, stronger coordination between clinical and scheduling services may be more useful. Where referrals are not reliably completed, the organization may need agreed communication arrangements with receiving facilities.

Clinicians, nurses, appointment coordinators, medical records personnel, and relevant information technology staff should contribute to improvement activities according to their responsibilities.

A manageable set of indicators can then be used to establish baseline performance and evaluate changes.

Introducing another electronic reminder or documentation template does not, by itself, demonstrate improvement.

The meaningful question is whether clinically important unresolved problems are being reassessed more reliably, whether appropriate referrals are completed, and whether the process avoids unnecessary investigations or excessive workload.

Patient feedback may also reveal unclear instructions or practical barriers to returning for care. This information can complement clinical quality review without replacing professional assessment of diagnostic appropriateness.

A sustainable program should strengthen continuity and professional judgment while making important diagnostic questions less likely to be lost across encounters.

From Repeated Consultations to Reliable Diagnostic Progress

Persistent and recurrent symptoms are common in primary care. Their presence does not automatically indicate serious disease or an earlier diagnostic error.

The challenge is that an initially reasonable assessment may become less satisfactory as the patient's condition changes. A symptom that has not improved as expected, the appearance of a new clinical finding, or an incomplete specialist evaluation may alter what the clinician needs to consider.

Diagnostic safety depends on whether the healthcare system recognizes those changes and provides an appropriate opportunity for reassessment.

The WHO's Primary Care Checklist, NICE's safety-netting recommendations, and research published in 2026 reinforce the importance of clear documentation, continuity, and reliable follow-up when diagnostic uncertainty remains.

For healthcare organizations in Viet Nam, the priority should be to establish practical mechanisms that help clinicians recognize unresolved diagnostic questions, reconsider earlier conclusions when new information emerges, and maintain appropriate follow-up across visits and healthcare settings.

This does not require repeated testing for every persistent symptom or automatic referral after a predetermined number of consultations.

It requires a process in which previous findings remain accessible, clinical conclusions can be reconsidered, and responsibility for the next step is clear when further evaluation is justified.

Diagnostic excellence in primary care is not demonstrated by reaching a definitive diagnosis at every first consultation. It is demonstrated by recognizing when uncertainty remains, reassessing symptoms as new information emerges, and ensuring that clinically important diagnostic questions are not lost over time.

Selected References and Regulatory Sources

World Health Organization. Primary Care Checklist. Technical Document. June 27, 2025.

National Institute for Health and Care Excellence. Suspected Cancer: Recognition and Referral. NICE Guideline NG12. Originally published June 23, 2015; last updated April 15, 2026. Particularly the recommendations on patient support, safety-netting, and the diagnostic process.

Fernholm R, Kappelin C, Nemlander E. Documentation-Related Diagnostic Safety Concerns in Primary Care: A Structured Medical Record Review of 1116 Patient Records. BMJ Quality & Safety. Published online September 17, 2026. DOI: 10.1136/bmjqs-2026-020701.

Salant T, Benneyan J, Zhong A, et al. Symptom Tracking in Primary Care: Designing and Testing an EHR-Embedded Safety-Net System. The Joint Commission Journal on Quality and Patient Safety. 2026;52(10):544–550. DOI: 10.1016/j.jcjq.2026.05.012.

National Academies of Sciences, Engineering, and Medicine. Improving Diagnosis in Health Care. Washington, DC: National Academies Press; 2015.

National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, particularly Articles 60, 64, and 69.

Government of Viet Nam. Decree No. 96/2023/ND-CP, detailing certain provisions of the Law on Medical Examination and Treatment, dated December 30, 2023, as amended where applicable.

National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. Effective January 1, 2026.

Government of Viet Nam. Decree No. 356/2025/ND-CP, detailing certain provisions and implementation measures of the Law on Personal Data Protection. Effective January 1, 2026.

Professional Scope and Disclaimer

This article is published by Diagnostic Excellence Vietnam (DxEx.vn), a professional initiative dedicated to advancing diagnostic quality, safety, and reliability in Viet Nam through evidence-informed knowledge sharing, risk management, measurement, and quality improvement.

The content is intended for general professional education and discussion. It does not constitute patient-specific medical advice, a clinical diagnosis, an individualized recommendation concerning symptom assessment, investigation, reassessment, or referral, a determination of professional or technical error, or legal advice. References to international guidelines and professional recommendations do not imply that they are automatically mandatory under Vietnamese law unless such requirements are independently applicable.

Patient-specific diagnostic assessment, interpretation of clinical findings, decisions concerning investigations, professional consultation, referral, treatment, and follow-up must be undertaken by appropriately qualified and authorized healthcare professionals in accordance with applicable Vietnamese law, relevant professional standards, and the patient's clinical circumstances. Symptoms suggesting an urgent or serious condition require assessment through appropriate clinical services rather than reliance on general educational information.

Diagnostic Excellence Vietnam does not provide clinical diagnosis or treatment services.